Medicines/finished pharmaceutical products

Reference Number: 
RH018 (a)

Date of prequalification: 
20 August 2010
Basis of listing: 
Prequalified by WHO
Status: 
Active
INN: 
Medroxyprogesterone acetate
Therapeutic area: 
Reproductive Health
Dosage form & strength: 
Suspension for injection 150mg/mL
Storage condition: 
Do not store above 25°C
Shelf life (months): 
60
Packaging: 
Vial Glass: 1ml
Applicant: 
Pfizer Manufacturing Belgium NV / SA, Rijksweg 12, Puurs 2870, Belgium
FPP Manufacturing Site: 

Pfizer Manufacturing Belgium NV / SA, Rijksweg 12, Puurs 2870, Belgium

FPP WHO Public Inspection Reports: 
API Manufacturing Site: 

(Medroxyprogesterone acetate) Valdepharm, 27106 Val De Reuil, Parc Industriel d'Incarville, Cedex, BP 606, France
(Medroxyprogesterone acetate) Pharmacia & Upjohn Co, 7000 Portage Road, Kalamazoo, Michigan, MI 49001, United States of America

API WHO Public Inspection Reports: